Following people with obstructive sleep apnea who use the Inspire System
Follows how people with obstructive sleep apnea use and respond to Inspire.
Key facts
- Who runs it
- Inspire Medical Systems, Inc.
- Where
- London and Manchester, United KingdomSee the 3 sitesAlso in 6 other countries, 18 sites
- Trial code
- Registry title
- EURO-STIM Registry
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 26 May 2025
- Expected to end
- Apr 2035
- Type of study
- Observational
- Treatments tested
- Inspire UAS System
- Record updated
- 8 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with obstructive sleep apnea who have, or are getting, an Inspire implant. It follows how people use the device during routine clinic visits.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Obstructive sleep apnea (breathing stops during sleep because the airway is blocked).
- Earlier treatment
- People must already have, or be receiving, an Inspire implant.
Main reasons for not taking part
- Expected to live less than one year
- The doctor judges the person unfit to take part
- Not able to give informed consent
- Not willing to return for routine clinic visits
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Any patient implanted with or receiving an Inspire implant, who meets the following criteria, is eligible to participate in the registry:
- Capable of giving informed consent, as required per institution
- Willing to return for routine clinic visits as required for Inspire therapy management
Who cannot take part
- Any patient who meets any of the following criteria will not be eligible to participate in the registry:
- Has a life expectancy of less than one year
- Any reason the clinician deems patient is unfit for participation in the study
Where in United Kingdom
Also in 6 other countries, 18 sites
- Guy's & St Thomas' NHS Foundation TrustLondon, United KingdomContact: Krizzia LammasNot yet recruiting
- University College London Hospitals NHS Foundation TrustLondon, United KingdomContact: Omursen YildirimNot yet recruiting
- Manchester University NHS TrustManchester, United KingdomContact: Sadie KhwajaNot yet recruiting
About the trial
What the trial wants to find out
The registry is to measure longitudinal outcomes and adherence of the Inspire System. The goal of the registry is to capture the life cycle of the patient's use of the Inspire System through routine clinical care visits. There are no required interventions or testing.
Treatments tested
- Inspire UAS System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Longitudinal Outcomes and Adherence of the Inspire System, EURO-STIM Registry
- Plain-language title
- Following people with obstructive sleep apnea who use the Inspire SystemGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 8 September 2025